The Drug Enforcement Administration (DEA) has added a National Prescription Drug Take Back Locator to help consumers find the sites where they can drop off unused prescription drugs.
The Drug Enforcement Administration (DEA) has added a National Prescription Drug Take Back Locator to help consumers find the sites where they can drop off unused prescription drugs.
The locator was added ahead of National Prescription Drug Take-Back Day on September 29 from 10 a.m. – 2 p.m. After consumers enter their address or zip code, they can find law enforcement collection sites in their area.
Many consumers have already taken part in the DEA's two annual National Prescription Drug Take-Back days. At the last event in April, citizens turned in a record-breaking 552,161 lb or 276 tons of unwanted or expired medications. More than 5,600 take-back sites in 50 states were involved.
Overall, the Take-Back program has removed more than 1.5 million lb of prescription medication from circulation. "While a uniform system of prescription drug disposal is being finalized, we will continue to sponsor these important take-back opportunities as a service in our communities," said DEA Administrator Michele M. Leonhart.
The take-back service is free and anonymous, and no questions are asked, according to the DEA. Take-back sites accept tablets, capsules, and all other solid dosage forms of unwanted medications.
Unlock the Benefits of Centralized Fulfillment for Pharmacists: A Comprehensive Guide
November 6th 2024Streamline your pharmacy operations with centralized fulfillment. Discover how automation and advanced software can improve patient care, reduce operational errors, and create a better work environment for pharmacists. Download our whitepaper to learn how centralized fulfillment can address rising prescription volumes and staffing shortages. Request a consultation today to explore the best solution for your pharmacy.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.